Pharmaceutical Technology Europe-01-01-2012

Pharmaceutical Technology Europe
Special Feature

January 01, 2012

PTE interviews Accu-Break's David Beach about using multilayer technology to create accurate breakable tablets and flexible fixed-dose combination drugs.

Special Feature
Pharmaceutical Technology Europe

January 01, 2012

Fixed-dose combinations (FDCs) reduce the number of pills that must be taken, but they have also been a topic of concern, mainly because of the perceived potential for increased adverse events. PTE speaks with researchers to explore the benefits and concerns of FDCs.

Pharmaceutical Technology Europe
Special Feature

January 01, 2012

Multilayer tablets: A piece of cake or just a passing fad? We bring experts together to find out.

Pharmaceutical Technology Europe

January 01, 2012

Firstly, Happy New Year! Please help yourself to a slice of cake.

Pharmaceutical Technology Europe
News

January 01, 2012

The past few years have witnessed some dreary numbers in both Europe and the US when it comes to new products, but 2011 figures released by the European Medicines Agency may be early indicators for a 2012 upturn.

Pharmaceutical Technology Europe

The next two years may see a shake up in the world's current top pharmaceutical companies, with Pfizer likely to be the only US firm to remain in the top five by sales.

Pharmaceutical Technology Europe
Special Feature

January 01, 2012

Multilayer tablets can be challenging, but meeting regulatory expectations is crucial. We speak with Vilayat Sayeed from the FDA, to find out more about the critical factors that need to be fully understood.